JCHAIN (joining chain) is a structural protein essential for assembling multimeric immunoglobulins, particularly IgM and IgA. Functionally, JCHAIN stabilizes IgM pentamers and hexamers by capping the tailpiece assembly in an amyloid-like structure, forming a nucleation unit for higher-order polymers 1. The J-chain bridges interactions between immunoglobulin Fc regions and the polymeric immunoglobulin receptor (pIgR), enabling transcytosis from vasculature to mucosal surfaces 2. Similarly, JCHAIN promotes IgA dimerization and larger polymer formation, facilitating secretory IgA immune responses 3. Clinically, JCHAIN dysregulation is implicated in multiple pathologies. In IgA nephropathy, upregulated JCHAIN in mesangial cells triggers pathological IgA1 dimerization and glomerular deposition, contributing to kidney disease progression 3. In intrahepatic cholangiocarcinoma, elevated JCHAIN marks plasma cell+ infiltration patterns associated with improved patient survival, contrasting unfavorably with macrophage-dominant immune signatures 4. In rheumatoid arthritis, JCHAIN expression identifies bone marrow long-lived plasma cells producing pathogenic anti-citrullinated autoantibodies 5. Additionally, reduced JCHAIN expression correlates with epilepsy, suggesting impaired B-cell/antibody responses in neuroinflammatory disease 6. These findings highlight JCHAIN's dual role: essential for normal humoral immunity yet potentially pathogenic when dysregulated in autoimmune and malignant conditions.